Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis: Letter to the Editor

por Gooderham, M., Elewski, B.E., Pariser, D.M., Sofen, H., Mendelsohn, A.M., Rozzo, S.J., Li, Q.
Publicado 2019

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity

por Nelson, L. M., DiBenedetti, D., Pariser, D. M., Glaser, D. A., Hebert, A. A., Hofland, H., Drew, J., Ingolia, D., Gillard, K. K., Fehnel, S.
Publicado 2019

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

por Menter, A., Papp, K.A., Gooderham, M., Pariser, D.M., Augustin, M., Kerdel, F.A., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Chavers, S., Naessens, D., Sermon, J., Krueger, G.G.
Publicado 2016